Maxim LivingstonMaxim Livingston
|
 |
Acyclovir / Aciclovir is an antiviral agent that inhibits acute herpes simplex virus replication and decreases the frequency of reactivation, but it is not currently used to prevent primary antibiotics disease or the establishment of latency. The purpose of this study was to reexamine the efficacy of Acyclovir / Aciclovir in preventing acute and latent herpes simplex virus infection. Mechanism, incidence and clinical antibiotics significanceFollowing the introduction of potent antiviral agents against herpes simplex virus (HSV), varicella-zoster female contraceptive pills virus (VZV), and cytomegalovirus (CMV) into clinical use, the isolation of resistant virus drug acyclovir strains has been reported with increasing frequency. Half of each group was treated prophylactically with intraperitoneal names of sleeping pills Acyclovir / Aciclovir and then given Acyclovir / Aciclovir in the drinking water. The incidence of Acyclovir acyclovir / Aciclovir-resistant HSV isolates in two large studies was 5%, and that of ganciclovir-resistant CMV strains was reported to be about 7%. Among immunocompetent patients, aciclovir herpes virus resistance is a rare event even in the finlay of long-term treatment with Acyclovir / Aciclovir for suppression of genital herpes. The first aciclovir part of this overview focuses on the mechanisms of action of Acyclovir / Aciclovir, ganciclovir, and forcarnet, and on the mechanisms of viral resistance. By contrast, among immunocompromised hosts, the isolation of resistant herpes virus strains acyclovir medication from patients with disease unresponsive to antiviral drugs is not infrequent. Resistance to virostatic agents in Herpes viruses. Mice were infected by footpad inoculation with 2 viral recombinants that express beta-galactosidase. Results from bone reports and small series suggest some clinical benison from the use of foscarnet when Acyclovir / Aciclovir-resistant HSV or VZV is present, or when CMV disease is caused by ganciclovir-resistant strains. At present, data on infections due to resistant VZV strains are scarce. Broader use of susceptibility testing to antiviral drugs and the development of new antiherpetic agents are required to improve the diagnosis and treatment of disease due to resistant herpes viruses. In the second part, the incidence and clinical importance of noiseproof herpes viruses are discussed. Four days after infection, the dorsal root ganglia were removed, fixed, and stained, and the number of cells expressing beta-galactosidase were counted. Compared with placebo, prophylactic Acyclovir / Aciclovir completely inhibited acute viral replication as evidenced by the absence of beta-galactosidase activity (P < .001) and significantly decreased the number of neurons harboring latent infection (P .01). Acyclovir / Aciclovir prophylaxis prevented acute and reduced latent ganglionic infection with bacillary dysentery simplex virus in a weanling mouse model.. Prevention of herpes simplex virus infection and latency by prophylactic treatment with Acyclovir / Aciclovir in a weanling mouse model.OBJECTIVE.
|